High-fat Diet (HFD) and Small Intestinal Microbiome
NCT07019142 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2025-06-13
Summary
The investigators aim to characterize the upper small intestinal microbiome in healthy conditions in dependency on feeding condition (starved vs. high-fat-challenged) and diet (before and after 3 day high-fat-diet)
Primary outcome will be the maximum culturable bacteria (aerobic and anaerobic) in small intestinal luminal content during acute liquid-fat challenge before vs. after a short-term (3 day) high-fat-diet
In this pilot study, healthy volunteers will undergo i) an upper endoscopy for harvesting of small intestinal juice, mucosal biopsies and ii) blood withdrawal at baseline (starved) as well as during acute one-time high-fat luminal stimulation (within 3 hours after baseline) utilizing microbiological culture and 16S-RNA sequencing. The same procedure will be performed after 3 day high-fat-diet.
During endoscopy an acute luminal high-fat challenge which will be repeated after a short-term (3 day) high-fat diet
Conditions
- Microbial Colonization
- Small Intestinal Bacterial Overgrowth
Interventions
- DIETARY_SUPPLEMENT
-
HFD
Luminal challenge with standardized volume, amount, calories of fat
Sponsors & Collaborators
-
Insel Gruppe AG, University Hospital Bern
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-03-01
- Primary Completion
- 2024-05-31
- Completion
- 2024-11-01
Countries
- Switzerland
Study Locations
More Related Trials
-
Freeze-dried, Capsulized FMT for RCDI
NCT02399618 ·Status: UNKNOWN ·Phase: PHASE1
-
The Role of Mucosal Microbiome in Recurrence of Clostridioides Difficile Infection
NCT04675723 ·Status: COMPLETED
-
The Characteristics and Role of Mucosal Microbiome After Treatment of Clostridioides Difficile Infection
NCT04668014 ·Status: COMPLETED
-
FMT for Moderate to Severe CDI: A Randomised Study With Concurrent Stool Microbiota Assessment
NCT02570477 ·Status: UNKNOWN ·Phase: NA
-
Characterization of the Microbiome in Peritoneum, Jejunum, Rectum and Stool
NCT04067440 ·Status: COMPLETED
-
Fecal Bacterial Flora in Clostridium Difficile-Associated Diarrhea
NCT00304876 ·Status: COMPLETED
-
Studies of the Human Microbiome in Clinical Center Patients
NCT01933620 ·Status: ENROLLING_BY_INVITATION
-
A Flexible Clinical Trial to Test if Freeze-dried Fecal Microbiota Therapy Helps Treat Diarrhea-predominant Irritable Bowel Syndrome or Prevent Recurring C. Difficile Infections.
NCT06948461 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Lyophilized Fecal Transplant vs Lyophilized Fecal Filtrate in Recurrent C Diff Infection
NCT03353506 ·Status: COMPLETED ·Phase: PHASE2
-
Fecal Microbiota Transplantation to Treat Recurrent C. Difficile Associated Diarrhea Via Retention Enema or Oral Route
NCT02449174 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Fecal Microbiota Transplant for Relapsing Clostridium Difficile Infection in Adults and Children Using a Frozen Encapsulated Inoculum
NCT01914731 ·Status: COMPLETED ·Phase: PHASE1
-
Placebo Controlled Study of Fecal Microbiota Transplant (FMT) for a First or Second Episode of C. Difficile Infection in Adults Using a Frozen Encapsulated Inoculum
NCT02343328 ·Status: TERMINATED ·Phase: PHASE1
-
Fecal Microbiota Transplant (FMT) for Relapsing C. Difficile Infection in Adults and Children Using a Frozen Inoculum
NCT01704937 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of Multiple Daily Dosing of Oral LFF571 in Patients With Moderate Clostridium Difficile Infections
NCT01232595 ·Status: COMPLETED ·Phase: PHASE2
-
Intestinal Lavage for the Treatment of Severe C. Difficile Infections
NCT02466698 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Mucosal and Microbiota Changes During Acute Campylobacteriosis
NCT03223077 ·Status: RECRUITING
-
Multi-Centre Trial of Fresh vs. Frozen-and-Thawed FMT for Recurrent CDI
NCT01398969 ·Status: COMPLETED ·Phase: PHASE2
-
Probiotics Administration Via Colonoscopic Spray and Oral Administration in CDAD Patients
NCT05770726 ·Status: RECRUITING ·Phase: NA
-
Study of Metronidazole Delayed-Release Capsules in Comparison With Immediate-Release Tablets (Flagyl) for Safety and Pharmacokinetics
NCT07251127 ·Status: COMPLETED ·Phase: PHASE1
-
Multicentre Blinded Comparison of Lyophilized Sterile Fecal Filtrate to Lyophilized Fecal Microbiota Transplant in Recurrent Clostridioides Difficile Infection
NCT03806803 ·Status: COMPLETED ·Phase: PHASE2
-
Research on Gut Microbiome and Metabolomics Alterations in C.Difficile Infected IBD Patients
NCT05714566 ·Status: RECRUITING
-
The Impact of Food on Gut Microbiome Composition - a Clinical Trial Determining the Influence of Diet in Gut Microbiome Colonisation and Host Health
NCT05986955 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Evaluation of the Variation of the Intestinal Microbiota and the Integrity of the Intestinal Barrier in Patients With M.D.R. Germ-induced Pneumonia Undergoing Enteral Nutrition
NCT06485791 ·Status: NOT_YET_RECRUITING
-
Clostridioides Difficile Controlled Human Infection Model
NCT06702345 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Addition of Lactobacillus to Metronidazole in Treatment of CDAD
NCT00304863 ·Status: WITHDRAWN ·Phase: PHASE4